Allied to this, the loss of both TAL1 and E47 proteins is dose-dependent (Figure 3A), while there was no detectable loss of LYL1 (another T-ALL implicated bHLH protein), GATA3, or LDB1. The gene discussed is GATA3; the disease is acute lymphoblastic leukemia.